Posts tagged Axis Securities
Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
| Axis Top Picks basket has outperformed the benchmark by a significant margin due to thematic approach to Top Picks selection | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | January 15, 2023 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 54% |
| Summary: | Axis Top Picks basket outperformed the benchmark by a significant margin as it delivered an impressive return of 11% in 2022 as against 4.3% posted by Nifty 50 during the year |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Top 6 Festival Unlock Stocks By Axis Securities | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | September 25, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 19% |
| Summary: | Festival Unlock Picks September 2021 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| NIFTY target raised to 17400 + Top 16 Small Cap, Mid Cap and Large Cap Stocks To Buy | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | July 1, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 33% |
| Summary: | Raise December NIFTY target to 17400 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio, NIFTY, Top Picks |
| Navin Fluorine Has Strong Growth Chemistry: Axis Securities | |
| Company: | Navin Fluorine |
| Brokerage: | Axis Securities |
| Date of report: | June 17, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Strong Growth Chemistry |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Navin Fluorine |
| Covid 2.0: Investment Ideas | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | April 23, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 39% |
| Summary: | Reduce NIFTY50 target to 16100 but remain cautiously optimistic |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Axis Top Picks for April 2021 | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | April 1, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | New Fiscal; New Hope! |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Gland Pharma Initiating Coverage Research Report By Axis Securities | |
| Company: | Gland Pharma Ltd |
| Brokerage: | Axis Securities |
| Date of report: | March 9, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 15% |
| Summary: | Well-positioned to Capitalise Fast-growing Generic Injectibles Market |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Gland Pharma Ltd |
| NIFTY Target Upgraded To 17,200 + Best 15 Stocks To Buy Now: Axis Securities Report | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | March 2, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 36% |
| Summary: | Structural trends intact; Upgrade Nifty Target to 17,200 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Top 10 Fundamentally Strong Stocks To Buy Now To Benefit From Stock Market Crash: Axis Securities | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | February 26, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | Opportunities in times of adversity! |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Buy Camlin Fine Sciences For 46% Upside Gain: Axis Securities | |
| Company: | Camlin Fine Sciences |
| Brokerage: | Axis Securities |
| Date of report: | February 19, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 46% |
| Summary: | Strategically Integrated Player |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Camlin Fine Sciences |